Time of Day Affects Immune Cells: New MS Treatment Tip

Credibility

Interest

Share:2 min read

Key Takeaway

The body's internal clock affects immune cells that can worsen MS, and blocking a specific immune receptor (FPR2) reduced disease in a mouse model.

What They Found

In a mouse model of MS, a type of immune cell called neutrophils rose in the blood before symptoms appeared. These neutrophils entered the brain and spinal cord more at certain times of day, especially when the mice became active in the evening. Neutrophils in the central nervous system showed different gene activity depending on the time of day, like workers changing tools for a night shift. The researchers found one receptor, FPR2, that was more active and could be blocked by a drug to reduce disease signs. Combining the FPR2 blocker with a drug that stops immune cells from entering the brain (similar to a current MS therapy) worked even better at lowering symptoms.

Who Should Care and Why

People with MS and their caregivers should care because this study suggests when immune cells act may matter for symptoms and treatment timing. Think of your immune system like a city: traffic (cells) may surge at rush hour, so timing a roadblock (drug) could cut damage. Patients on therapies that limit immune cells entering the brain might get extra benefit if treatment timing or added drugs target these neutrophils. Caregivers and healthcare teams could consider that symptoms or relapses might be influenced by daily rhythms, which could affect planning activities or medication schedules. Researchers and doctors may use this idea to design better treatments that combine existing drugs with timing or new blockers like FPR2 inhibitors.

Important Considerations

This study was done in mice, not people, so results may not work the same way in humans. The specific drug effects were tested in a controlled lab model, and safety or timing details for people are not known yet. More research and clinical trials in humans are needed before changing treatment plans or timing for MS patients.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research Treatment Updates Specific Symptoms

Article Topics:

circadian rhythmmultiple sclerosisneutrophil

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Proceedings of the National Academy of Sciences of the United States of America often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News